Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1899 1
1933 1
1941 1
1943 1
1944 1
1946 2
1949 3
1950 3
1951 2
1952 1
1953 2
1954 2
1955 1
1957 3
1958 1
1960 2
1961 2
1962 2
1963 1
1964 1
1965 3
1966 2
1967 1
1968 1
1969 5
1970 3
1971 3
1972 1
1973 5
1974 6
1975 9
1976 11
1977 4
1978 4
1979 6
1980 5
1981 4
1982 6
1983 2
1984 6
1985 6
1986 6
1987 8
1988 5
1989 6
1990 3
1991 6
1992 6
1993 4
1994 1
1995 5
1996 5
1997 4
1998 2
1999 5
2000 3
2001 8
2002 2
2003 2
2004 4
2005 2
2006 1
2007 9
2008 10
2009 10
2010 15
2011 13
2012 19
2013 18
2014 26
2015 33
2016 37
2017 22
2018 31
2019 26
2020 25
2021 26
2022 34
2023 26
2024 20
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

568 results

Results by year

Filters applied: . Clear all
Page 1
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Han JK, Bachert C, Fokkens W, Desrosiers M, Wagenmann M, Lee SE, Smith SG, Martin N, Mayer B, Yancey SW, Sousa AR, Chan R, Hopkins C; SYNAPSE study investigators. Han JK, et al. Among authors: smith sg. Lancet Respir Med. 2021 Oct;9(10):1141-1153. doi: 10.1016/S2213-2600(21)00097-7. Epub 2021 Apr 16. Lancet Respir Med. 2021. PMID: 33872587
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count.
Bachert C, Sousa AR, Han JK, Schlosser RJ, Sowerby LJ, Hopkins C, Maspero JF, Smith SG, Kante O, Karidi-Andrioti DE, Mayer B, Chan RH, Yancey SW, Chaker AM. Bachert C, et al. Among authors: smith sg. J Allergy Clin Immunol. 2022 May;149(5):1711-1721.e6. doi: 10.1016/j.jaci.2021.10.040. Epub 2022 Jan 7. J Allergy Clin Immunol. 2022. PMID: 35007624 Free article. Clinical Trial.
Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination Immunotherapy.
Iyer S, Zhang S, Yucel S, Horn H, Smith SG, Reinhardt F, Hoefsmit E, Assatova B, Casado J, Meinsohn MC, Barrasa MI, Bell GW, Pérez-Villatoro F, Huhtinen K, Hynninen J, Oikkonen J, Galhenage PM, Pathania S, Hammond PT, Neel BG, Farkkila A, Pépin D, Weinberg RA. Iyer S, et al. Among authors: smith sg. Cancer Discov. 2021 Feb;11(2):384-407. doi: 10.1158/2159-8290.CD-20-0818. Epub 2020 Nov 6. Cancer Discov. 2021. PMID: 33158843 Free PMC article.
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-up.
Desrosiers M, Diamant Z, Castelnuovo P, Hellings PW, Han JK, Peters AT, Silver J, Smith SG, Fuller A, Sousa AR, Chan RH, Gevaert P; SYNAPSE study investigators. Desrosiers M, et al. Among authors: smith sg. Int Forum Allergy Rhinol. 2024 Jan;14(1):18-31. doi: 10.1002/alr.23219. Epub 2023 Jul 18. Int Forum Allergy Rhinol. 2024. PMID: 37345861 Clinical Trial.
Motion analysis.
Smith SG, Torkington J, Brown TJ, Taffinder NJ, Darzi A. Smith SG, et al. Surg Endosc. 2002 Apr;16(4):640-5. doi: 10.1007/s004640080081. Epub 2001 Dec 17. Surg Endosc. 2002. PMID: 11972205
Mepolizumab Reduces Systemic Corticosteroid Use in Chronic Rhinosinusitis With Nasal Polyps.
Chupp G, Alobid I, Lugogo NL, Kariyawasam HH, Bourdin A, Chaker AM, Smith SG, Sousa AR, Mayer B, Chan RH, Matucci A. Chupp G, et al. Among authors: smith sg. J Allergy Clin Immunol Pract. 2023 Nov;11(11):3504-3512.e2. doi: 10.1016/j.jaip.2023.08.015. Epub 2023 Aug 14. J Allergy Clin Immunol Pract. 2023. PMID: 37586475 Free article. Clinical Trial.
568 results